Citation Methodology Participant population characteristics PM materials assessed PM results type Barajas et al. [20 ] Focus groups 17 Patients currently taking warfarin Educational tool developed as part of the study design Hypothetical scenarios Brewer et al. [23 ] Randomized trial 133 Patients with positive early stage breast cancer diagnosis Results developed as part of the study design Hypothetical results Giuse et al. [18 ] Randomized controlled trial 88 Patients with positive melanoma diagnosis or their caregivers Educational tools developed as part of the study design Hypothetical results Kaphingst et al. [19 ] Observational 199 Patients enrolled in health maintenance organization Results developed from best practices in health literacy Actual patient results Leighton et al. [16 ] Observational 145 General public Commercially available DTC report Hypothetical results 171 Genetic counselors Liang et al. [27 ] Interview 16 Patients with nonsmall cell lung cancer Results previously provided from molecular testing Actual patient results 8 Patients with melanoma Olson et al. [26 ] Observational 869 Patients in the Mayo Clinic Biobank A summary and full report of pharmacogenomic test results Actual patient results Ostergen et al. [22 ] Observational 1030 Current consumers of personal genomic testing Commercially available DTC report Hypothetical results Shaer et al. [24 ] Randomized controlled trial 730 General public Results developed as part of the study design Hypothetical results Stuckey et al. [21 ] Semistructured interviews; focus groups 9 Parents of children enrolled in genome sequencing clinical research study Results developed as part of the study design Hypothetical results
